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Avian intestinal spirochaetosis (AIS) is a common disease occurring in poultry that can be caused by Brachyspira
pilosicoli, a Gram-negative bacterium of the order Spirochaetes. During AIS, this opportunistic pathogen colonises
the lower gastrointestinal (GI) tract of poultry (principally, the ileum, caeca, and colon), which can cause symptoms
such as diarrhoea, reduced growth rate, and reduced egg production and quality. Due to the large increase of bacterial
resistance to antibiotic treatment, the European Union banned in 2006 the prophylactic use of antibiotics as growth
promoters in livestock. Consequently, the numberofoutbreaks of AIS has dramatically increased in the UK resulting
in significant economic losses. This review summarises the current knowledge about AIS infection caused by
B. pilosicoli and discusses various treatments and prevention strategies to control AIS.
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C
ontrolled animal husbandry is essential in order
to ensure safe and sustainable food production.
Animal husbandry is commonly practiced in
developed and some developing countries (1) as reported
by the USDA and Eurostat (2, 3). The constant optimisa-
tion of breeding techniques and increased production
efficiencies has reduced significantly the price of meat and
dairy products over the years, providing wider access
to products derived from animals in countries where they
were not traditionally consumed (1). Therefore, there is
a growing interest in improving breeding methods to
improve animal welfare, reduce production costs, and
ensure higher safety and better quality for consumers.
In this context, it is particularly relevant to reduce diseases
of animal production, especially those that have zoonotic
potential. Gastrointestinal (GI) diseases are common in
production animals, and their incidence has increased in
large-scale farming industry due to intensive farming
practices, which facilitate rapid spread of infection be-
tween animals (4). GI disorders in such facilities often
result from the colonisation of the GI tract by pathogenic
microorganisms, particularly at certain times in the
production cycle such as weaning (5). Brachyspira
pilosicoli that induces intestinal spirochaetosis (IS) is
an emerging pathogen causing infections in a number
of species, including poultry, which is the subject of this
review. While Brachyspira spp. are found in intensive
husbandry, Brachyspira spp. infection are particularly
common in free-range and organic farms (6, 7) due to
the higher exposure of flocks to wild birds and the
environment, which act as infection vectors/reservoirs (7).
IS is a generic name given to largely diarrhoeal disease
caused by the colonisation of the lower GI tract by
Spirochaetes of the genus Brachyspira, and more specifi-
cally for poultry by B. pilosicoli (4, 7), B. alvinipulli (8), and
B. intermedia that are Gram-negative, spiral organisms
with flexible outer-membrane and inter-membrane polar
flagella (810 depending on species) possessing single
circular genome comprising 45,000 genes and a guanine
cytosine (GC) ratio of 27%. Pathogenic Brachyspira spp
are presented in Table 1 with their host range and
pathogenicity (9). Other Brachyspira spp. (not listed for
brevity) are non-pathogenic but may be found in mixed
infections. Also B. hampsonii is a newly described type
pathogen in several species including poultry, which is yet
to be defined and accepted as a new species. B. pilosicoli is
an opportunistic pathogen generally associated with swine
and poultry but has also been reported to infect other

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animals including dogs, horses, monkeys, turkeys, geese,
and humans (1013).
Avian intestinal spirochaetosis (AIS), caused by the
colonisation of the lower GI tract by bacteria of the
genus Brachyspira in birds, generally occurs in breeder and
egg-laying chickens but also increasingly in broilers. The
infection triggers severe diarrhoea accompanied by loss
of weight, which has been associated with increased
morbidity among flocks with 510% mortality if untreated
with concurrent loss of egg production in layers (1417).
It often occurs by transmission of the spirochaetes via the
faecaloral route and can be transferred between livestock
buildings by farmers (4, 18, 19). Increasing number of
recent publications have reported the presence of
Brachyspira species in farms all over the world (20). This
observation could result from several parameters such as
the 2006 European Union ban on the prophylactic use of
antibiotics (4, 21), the modification of animal housing,
and finally the development of improved detection meth-
ods for this specific genus (22, 23). Thus, the impact of this
disease on animal welfare and production is of high
concern to the poultry industry enhancing needs for novel
intervention strategies to reduce the spread of AIS.
Here, we review the current knowledge on AIS caused
by B. pilosicoli and discuss the therapeutic and prophylac-
tic strategies currently investigated (including antibiotics
and probiotics). Vaccine development to protect from
swine dysentery (SD), a disease caused by Brachyspira
hyodysenteriae infection in pigs (24), is also in process.
Similarly, the development of autogenous vaccines for AIS
(25) is just emerging. As progress regarding these inter-
ventions is still extremely limited, it will not be discussed
further in this review.
Overview of the disease
Signs and symptoms
B. pilosicoli-induced AIS is generally observed in egg-
laying chickens over 10 weeks old in large rearing farms
(4, 26). Numerous cases have been reported worldwide,
especially in Europe, the US, and Australia, where in-
tensive farming offers suitable conditions for development
and spread of various GI infections including those caused
by Brachyspira.
Symptoms of infections by B. pilosicoli can range from
asymptomatic to severe, leading to increased mortality
rates in chickens (4, 27). Nevertheless, the most common
mild/moderate infections are generally characterised by
diarrhoea, faeces with altered colour and consistency,
which are frequently foamy due to increased gas produc-
tion (28), so-called cappuccino faeces. This may progress
to faeces containing mucus and blood (27). Diagnosis is
generally confirmed via bacterial culture or PCR (29).
AIS infection results in a slower growth rate (2830)
and can also be associated with a delay of up to 7 weeks in
the onset of lay accompanied by a decrease in egg quality
(2831). Eggs produced by infected hens are usually small,
lighter in weight (i.e. 26 g less per egg) (28), and are less
numerous. Poor-quality shells are prone to cracks and
often contaminated by faeces (32). Yolks are generally less
coloured with a decrease of 1.53 points on the Roche yolk
colour fan (28, 33). Furthermore, it has been suggested
that infection may have long-term consequences on the
second generation of chickens hatched from eggs laid
by infected hens (28). Indeed, it has been shown that
chicks hatched from eggs laid from infected female parents
presented similar symptoms (i.e. decreased weight gain,
delayed lay onset, wetter and paler faeces) despite the
absence of contamination (28). These results raise new
hypotheses regarding potential epigenetic variations in
response to B. pilosicoli infection.
At a microscopic level, intestinal biopsies of infected
chickens displaying the symptoms described above usually
reveal the presence of B. pilosicoli fixed to the cells of the
intestinal wall (27), which is suspected to be correlated
with the degree of enterocyte perturbation (27). Tissues
look inflamed, often with some signs of bleeding. The
intestinal wall shows evidence of a loss of microvilli (21).
The loss of microvilli results in perturbation of the
epithelial barrier permeability, which may contribute to
the decrease in weight gain and the increased amount
of water in faeces. The cytoplasm of enterocytes appears
damaged as indicated by abnormal vacuolation, con-
densation, and fragmentation of the chromatin and cell
Table 1. List of Brachyspira species, their host, and pathogenicity
Species Host Pathogenicity Reference
B. aalborgi Human, primates Mild to moderate (11)
B. alvinipulli Chicken, goose, Red breasted, merganser, dog Mild to severe (12)
B. hyodysenteriae Chicken, goose, mallard, common rhea, pig, rat, mouse Severe (13, 14)
B. innocens Chicken, pig, dog, horse None (15, 16)
B. intermedia Chicken, pig Mild to moderate (10)
B. murdochii Chicken, pig, rat None (10)
B. pilosicoli Chicken, pheasant, grey partridge, feral water birds, common rhea, pig,
dog, horse, primates, human
Mild to moderate (18)
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sloughing (21). This is likely to result in lower nutrient
absorption as indicated by increased food consumption in
infected chickens (31) accompanied by increased faecal
lipid content concomitant with decreased lipid levels in
the general circulation (34). The same phenomenon has
been observed for carotenoid concentration, which has
been found in higher quantity in faeces of infected animals,
while lower in blood, and is believed to be the cause of
weakened colour intensity of the yolk (28, 34).
Characteristics and mechanism of infection
Morphology
B. pilosicoli is a bacterium of the order Spirochaetales,
morphologically characterised by a corkscrew-like shape
(35) (Fig. 1). It was first identified as a cause of IS in
Denmark in 1982 (27). B. pilosicoli can be found in the
literature under the former name of Serpulina pilosicoli
(27, 36). It is a Gram-negative, fastidious, aerotolerant
anaerobe that can be exposed to oxygen for a few hours
(4, 37). The optimum growth temperature is 38.58C (27),
but it can remain viable for 66 days at 48C in water
and survive up to 210 days in pig faeces mixed with soil
at 108C (37).
B. pilosicoli is constituted of a central protoplasmic
cylinder covered by a membrane sheet (27). The membrane
sheet, also known as the outer membrane, is an impor-
tant element for the integrity of the bacterium. Several
studies have shown that a perturbation of the membrane
generally causes the destruction of the flagella and of the
periplasmic membrane (38). The composition of the outer
membrane is not entirely known despite its high relevance
to host-pathogen interactions. Yet it has been shown to be
extremely labile due to its high content in sterols (choles-
terol and cholestanol), which are responsible for a low
resistance to osmotic stress and to low ionic buffers that
trigger its destabilisation (39). Between the outer mem-
brane and the protoplasmic cylinder is the periplasm,
where the flagella of the bacteria are located. B. pilosicoli
possesses between 8 and 10 flagella disposed equally at
the poles at each end of the bacterium following the
corkscrew shape of the bacterium and overlapping in the
centre (4, 27) (Fig. 1). This configuration is specific to
the Spirochaetes and confers high motility, which consti-
tutes an important virulence factor. The flagella works
by producing helical or flat sinusoidal waves (34), which
induce a clockwise or anticlockwise movement of the
bacteria and enable a non-transversal swim (41, 42).
A transversal swim is also possible by the simultaneous
combination of the two movements (41). Both modes of
movement provide B. pilosicoli with the ability to swim
through viscous media (43).
Infection process
B. pilosicoli infects the lower GI tract of chickens, swine,
horses, dogs, humans, and other animals (37). Upon entry
via the oral cavity, the bacterium that survives passage
through the stomach acid reaches the intestinal lumen.
Using chemotaxis, the organism migrates towards the
mucus and the intestinal wall (44, 45). Indeed, B. pilosicoli
has a high number of genes coding for chemotaxis towards
the mucus in comparison to other known bacterial species,
providing a significant advantage to colonise the host
(46). The mucus is a viscous matrix composed of two
stratums, the inner and outer layers, which form a physical
barrier and protect the intestinal cells from bacterial
infections by limiting their motility (44). The unique
shape of B. pilosicoli, combined with the production of
specific enzymes that hydrolyse the mucus inner layer
(sialidase family-like proteins), confers them the ability to
swim through this medium and allow them to reach the
cell wall (42, 44). These are high virulence factors asso-
ciated with tissue damage (46). Another virulence factor
may be the noted sensitivity of B. pilosicoli to the chemo-
attractant serine, which is found in high concentration
in the mucus secreted by goblet cells (37, 38, 47).
Once the bacterium is in contact with an intestinal cell,
fixation occurs through proteinprotein interactions (48),
although the exact mechanism has not been fully ascer-
tained. B. pilosicoli attaches vertically to the cell wall
by one of its cylinder ends (36, 48) and can be found very
closely packed on the cell at a density ranging 2080
bacteria per cell, forming a ‘false brush border’ (37, 46).
Attachment of the bacterium is not necessarily associated
with symptoms of IS (4, 37) but an increase in bacterial
Fig. 1. Transmission electron microscopy illustrating the flagella of Spirochaetaceae. (A) [Adapted with permission from Yano et al. (40)].
(B) Graphic representation of picture A enhancing the visualisation of the flagella.
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concentration appears to be directly linked to the intensity
of the symptoms (37) as previously mentioned. Adherence
of B. pilosicoli to the cell membrane triggers a signal
that results in invagination of the apical membrane and
internalisation of the bacteria potentially resulting in cell
apoptosis. B. pilosicoli can also cross the intestinal barrier
by disrupting gap junctions (between cells), which in some
cases may allow it to enter the blood stream (4, 49). Indeed
systemic spread of B. pilosicoli has been reported in one
study showing evidence of colonisation of the spleen
and liver (50). However, this was not commonly observed,
and the mechanism by which the bacterium escapes the
immune system is not known yet. The infection process is
summarised in Fig. 2.
Genetic features
In addition to the aforementioned genetic functions,
a recent publication of B. pilosicoli B2904 complete
genome by Mappley et al. (46) (Fig. 3) identified key
genes responsible for some of B. pilosicoli infection-
and colonisation-related processes, such as chemotaxis,
mobility, adhesion, and host tissue degradation. The
B. pilosicoli genome analysis also provided new insights
into its metabolism. It revealed numerous genes involved
in carbohydrate transport and metabolism, such as
phosphoglucomutase that plays a key role in glycolysis.
These genetic observations correlated to phenotypic tests
using Biolog† technology (which evaluates the cell’s
ability to respire on a wide range of substrates) demon-
strated the ability of B. pilosicoli to use several types of
saccharides (e.g. glucose-6-phosphate) and oligosacchar-
ides (e.g. dextrin) as primary carbon sources. Finally,
another large section of the genome was allocated to
amino acid synthesis and transport. Those results repre-
sent a major advancement towards understanding the
interrelationship between metabolism and infection.
False brush
border
Nutrient 
absorption
 
Cell sloughing
and bleeding
Gap junction
disturbtion 
Infection vector
1 2
3
Brachyspira pilosicoli
Enterocyte
Gap junction
Liver
Spleen
1
3
4
5
Mucus layer
2
Fig. 2. Transmission and infection process of Brachyspira pilosicoli. White numbers on grey circles describe the contamination process:
1, transmission of contaminated material in a farm via a vector  wild animals, farmers, water, and other farm animals  to a housed
bird via oral route; 2, transmission of the bacterium to the rest of the flock; 3, persistence of infection between birds of a same folk.
Grey numbers in white circles describe the infection process once B. pilosicoli has reached the lower digestive tract: 1, chemotaxis
attraction of the bacteria towards the mucus and cell wall; 2, attachment of B. pilosicoli on the cells and formation of a ‘false brush
border’; 3, invasion of intestinal cells; 4, translocation to the blood stream; 5, systemic infection.
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Impact on the food chain: a zoonotic potential?
Intestinal spirochaetosis is relatively rare in humans as
it occurs mostly in immunocompromised patients. In
most cases, carriage by the host of the bacteria is often
asymptomatic, but following the apparition of any symp-
toms such as diarrhoea and abdominal pain, IS is
confirmed by biopsy (51, 52). Only in rare cases did an
infection by B. pilosicoli cause death of a patient as a result
of septicaemia (53). Such cases have only been observed
in elderly and immunocompromised patients or in popula-
tions living in dense areas with poor hygiene conditions
(5456).
Despite the rare occurrence of the disease in humans, a
major concern is the zoonotic potential of the bacterium
(49). Indeed, it has been suggested that B. pilosicoli is
able to survive and be transmitted to the consumer
via contaminated raw meat from infected chicken (57).
Several studies have shown considerable genetic simila-
rities between strains of B. pilosicoli infecting humans,
swine, and poultry, suggesting an ability to adapt to
various hosts (49). In 2012, Mappley et al. (46) carried
out a genetic comparison of three strains of B. pilosicoli
isolated from humans, chickens, and pigs, respectively.
This study showed that the genotype of these three strains
were very similar. However, some differences were noted
in the genome size and arrangement and in some putative
coding regions for carbohydrate, amino acid, and nucleo-
tide metabolism and transport (46). These data high-
lighted some fundamental genetic differences that are
reflected in their phenotype and may have implications
in host specificity and interspecies transmission (46),
although this has remained untested till date. More
structural rearrangements were observed in the strains
isolated from chicken and human in comparison to
the strains isolated from pig. Despite these variations,
the functional genome comparison showed a high level
of similarity in the features of the three strains except
for the aforementioned transporters and enzymes (46).
Additionally, genes involved in membrane fixation and
in b-haemolysis were common to the three strains, which
suggests a similar invasion and infection process between
the bacteria (46). These genetic and phenotypic data
indicate a high degree of similarity in infection processes
across species and may support the potential of trans-
mission of bacteria causing IS from farm animals to
humans (49) and, therefore, is a realistic issue that requires
attention. Prevention of IS spread in animal livestock is
currently achieved using antibiotics.
Antibiotics: a controversial solution
Various antibiotics such as the pleuromutilins, macrolides,
and lincosamides are currently used to control Brachyspira
infections in animals and have been shown to reduce
associated symptoms (58, 59). The most common anti-
biotic used in animal husbandry is tiamulin, a member of
the pleuromutilin family. By binding with the 50S region
of the ribosome, it inhibits amino acid binding during
protein synthesis (60). Tiamulin is used widely and has
Fig. 3. Circos circular representation of the complete B. pilosicoli B2904 genome with annotated genes. The genome is orientated from
the oriC and also displays the location of dnaA. Circles range from 1 (outer circle) to 7 (inner circle). Circle 1, COG-coded forward
strand genes; circle 2, COG-coded reverse strand genes; circle 3, forward strand tRNA; circle 4, reverse strand tRNA; circle 5, forward
strand rRNA; circle 6, reverse strand rRNA; circle 7, GC skew ((G-C)/(GC); red indicates positive values; green indicates negative
values). All genes are colour coded according to Cluster of Orthologous Group (COG) functions shown in the key table. [Adapted with
permission from Mappley et al. 2012 (46)].
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been shown to be efficient at controlling SD, which is
a severe GI disease in pigs caused by B. hyodysenteriae,
a close relative of B. pilosicoli, at a dose of 7.71 mg/kg
of body weight for a 5-day treatment. Nevertheless, the
lack of standardised methods and techniques used to
calculate the minimum inhibitory concentration (MIC)
induces a large disparity in published results. Only two
studies describing the impact of tiamulin on B. pilosicoli-
induced AIS in chicken have been reported  in 2002,
in experimentally infected laying hens (61), and in 2006, in
a UK field study (62). Results suggest a positive impact of
tiamulin treatment in both studies with a general increase
in growth rate, egg production, and decrease of symptoms.
Another customer concern is the possible presence
of antibiotics and their metabolites in eggs, although
this has not been reported in the literature. One report
issued by the European Medicine Agency mentioned very
low antibiotic residual levels, but these were not sufficient
to establish a withdrawal period for eggs [Article 34(1)
of Directive 2001/82/EC (63)]. Nonetheless, a withdrawal
period of 24 h should be applied for meat consumption
[Article 34(1) of Directive 2001/82/EC (63)].
Furthermore, emerging bacterial resistance to antibio-
tics is another major concern (58, 64). For example,
tylosin was a commonly used antibiotic to treat AIS, but
resistance has recently emerged, compromising its effi-
ciency and therefore its usage (65). Resistance factors
appear as a consequence of an extensive use of antibiotics
concomitant with the development of mutations in the
bacteria such as on the ribosomal protein (66), which
render them less susceptible. This stresses the importance
of bacteriological diagnosis that should be used to
determine precisely the Brachyspira species responsible
of infection followed by antibiotic resistance test on
pure culture in order to apply appropriate treatment. In
response to the global rise of bacterial resistance and to
protect the consumer’s safety, the European Commission
banned the prophylactic use of antibiotics in livestock
in 2006 (67). Indeed, chickens grown in industrial farms
used to receive prophylactic antibiotic treatments, which
was also associated with increased animal fattening
rate (67). Since this interdiction, infection outbreaks by
B. pilosicoli have boomed (21, 67). Common consequences
include reduced egg production, growth delay, higher food
consumption, and, in some cases, increased mortality
within infected flocks. Since 2006, the economic loss
associated with AIS has been estimated to be of approxi-
mately £18 million per year in the UK (Burch, D. J. S., 2009
personal communication) pointing to the need for better
prevention methods and refined treatments. Prevention of
AIS outbreaks can be achieved using appropriate hygiene
and biosecurity rules as demonstrated by several studies
(68). B. pilosicoli is readily eliminated by standard farm
disinfection processes (69), and the potential of vaccina-
tion against B. pilosicoli has been explored primarily in
pigs and may be applicable in poultry (70). However,
treatment is commonly achieved using antibiotics such as
linco-spectin and tiamulin at 25 mg/kg of body weight per
day, although this dosage regimen is derived from studies
in pigs. Recently, we investigated the optimum dose to treat
laying hens and demonstrated that 250 ppm given in
drinking water over 3 days reduce infection significantly,
but the bacterium was still detectable at the end of
the study (3 weeks after the end of the treatment) (71).
Notwithstanding the use of antibiotic for intervention,
it remains crucial to find alternative solutions to prevent
AIS to protect animal welfare and consumers.
Probiotics: a potential solution?
The gut microbiota (GM) is estimated to be composed
of more than 1,000 species of bacteria (68) which are
predominantly Gram-negative (72). They exert an impor-
tant role for the host as they are involved in its protection
from pathogens and in the release of nutrients from the
diet, which would otherwise be unavailable to the host (72).
Beyond the positive impact of commensal bacteria on
the digestive system and associated nutritional benefits,
increasing evidence reveals a systemic impact of the
GM on the host (73). Probiotics, which are defined as
‘live microorganisms which when administered in ade-
quate amount confer a health benefit on the host’ (74),
have been developed to take advantage of this symbiosis.
Protection is achieved by increasing the competition
between the probiotic and pathogens for cell membrane
receptors and nutrients, modulation of the immune sys-
tem, improvement of the mucosal barrier permeability,
secretion of toxins, and lowering the pH of the GI (75, 76).
Their mechanisms of action vary depending on the
probiotic, but most of them remain largely misunderstood.
Only a few studies have investigated the impact of
Lactobacillus-based probiotics on B. pilosicoli, and most
of them have been carried out in vitro. It has been
shown that lactic acid secreted by lactobacilli has similar
effects as other acidic compounds and disinfectants on
B. pilosicoli, whereby the bactericidal effect is mediated
by destabilisation of the cellular wall hence reducing the
bacterial viability (77). Another interesting effect of lactic
acid is that it induces the formation of ‘spherical bodies’
formed by the retraction and swelling of both ends of
the bacterium, which tends to create a sphere shape. At
this stage, the bacterium is still viable but in a dormant
state (78).
Two promising Lactobacillus species to tackle AIS are
L. salivarius and L. reuteri. They are both recognised by
the European Food Safety Authority (EFSA), generally
regarded as safe (GRAS) and suitable for livestock feeding
(79). A recent study has shown that both lactobacilli
antagonise motility, growth, and cellular adherence of
B. pilosicoli (21). In vitro, it appears that the presence of
L. reuteri and L. salivarius reduces markedly the potential
Caroline I. Le Roy et al.
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of B. pilosicoli to induce apoptosis of intestinal cells (21)
by antagonising adhesion to the intestinal epithelium, in
a process of competitive exclusion. An in vivo study
indicated that Lactobacillus probiotic can prevent poten-
tial infection and associated symptoms caused by the
pathogen if administered before or during challenge with
B. pilosicoli (80), supporting its efficiency as a protective
agent against AIS.
Another advantage of using probiotics in farms is
their potential as animal growth promoters when used as
prophylactic (8183). In a study by Yoruk et al. (82), it was
demonstrated that probiotic consumption by laying hens
resulted in decreased mortality and increased egg production
without altering quality. Furthermore, the consumption of
Lactobacillus-based probiotic during the first 3 weeks of
life was shown to increase animal growth, demonstrating
their potential as growth promoters in the early stages of
life (83). Probiotics may also be useful to prevent infection
relapse that is often observed with AIS. Indeed by main-
taining a healthy and balanced gut environment, probiotic
could potentially be used in order to inhibit B. pilosicoli
recurrence postantibiotic treatment (20).
Conclusions
B. pilosicoli-induced AIS is a growing and underestimated
problem in the poultry industry. However, its occurrence
and economic burden is not negligible. Antibiotics such as
tiamulin are still considered as a gold standard to tackle the
infection, although resistance is emerging, which stimulates
the need for the development of new interventions. Despite
these promising novel therapies, there remains a large gap in
the understanding of the pathogen itself, particularly its
metabolism, although some new insights were given recently
by the genetic mapping of a few strains of B. pilosicoli.
Characterising these pathways would provide a major
advantage in AIS understanding in order to design more
targeted treatments. Finally, combination therapies that use
an antibiotic followed by an appropriate probiotic may be
worthy of consideration to prevent relapse by strengthening
the gut microbial community.
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